|
Volumn 301, Issue 1, 2009, Pages 65-70
|
Drug-induced subacute cutaneous lupus erythematosus: A paradigm for bedside-to-bench patient-oriented translational clinical investigation
|
Author keywords
Bedside to bench patient oriented translational clinical investigation; Drug induced subacute cutaneous lupus erythematosus
|
Indexed keywords
ALPHA INTERFERON;
AMIDE;
CAPTOPRIL;
CILAZAPRIL;
CINNARIZINE;
DILTIAZEM;
DOCETAXEL;
ETANERCEPT;
GLIBENCLAMIDE;
GRISEOFULVIN;
HYDROCHLOROTHIAZIDE;
HYDROXYCHLOROQUINE;
INFLIXIMAB;
LEUFONAMIDE;
NAPROXEN;
NIFEDIPINE;
NITRENDIPINE;
OMEPRAZOLE;
OXPRENOLOL;
PENICILLAMINE;
PHENYTOIN;
PIROXICAM;
PRAVASTATIN;
PROCAINAMIDE;
RANITIDINE;
SIMVASTATIN;
SPIRONOLACTONE;
TERBINAFINE;
TRIETHYLPERAZINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CLINICAL RESEARCH;
DISEASE ACTIVITY;
DISEASE ASSOCIATION;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
LICHENOID;
PATHOGENESIS;
PHOTOSENSITIVITY;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
SKIN LUPUS ERYTHEMATOSUS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
AUTOANTIBODIES;
AUTOANTIGENS;
BIOMEDICAL RESEARCH;
BRONCHIAL PROVOCATION TESTS;
CALCIUM CHANNEL BLOCKERS;
FEMALE;
HEALTH PLANNING GUIDELINES;
HUMANS;
HYPERTENSION;
LICHENOID ERUPTIONS;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
MIDDLE AGED;
PHOTOSENSITIVITY DISORDERS;
RIBONUCLEOPROTEINS;
RNA, SMALL CYTOPLASMIC;
SODIUM CHLORIDE SYMPORTER INHIBITORS;
WITHHOLDING TREATMENT;
|
EID: 58149174223
PISSN: 03403696
EISSN: None
Source Type: Journal
DOI: 10.1007/s00403-008-0890-x Document Type: Review |
Times cited : (87)
|
References (19)
|